Relações cineantropométricas e fisiológicas durante exercício incremental em esteira rolante

Testes incrementais em esteira rolante são muito utilizados para prescrição de treinamentos, havendo alterações fisiológicas e cinemáticas devido à natureza de incremento da intensidade do exercício. Contudo, a antropometria é um fator que não apresenta consenso na literatura. Neste sentido, os objetivos do presente estudo foram verificar o efeito de exercício incremental na concentração de lactato sanguíneo ([LAC]), e glicose ([GLI]), como também na frequência (FP) e amplitude de passadas (AP). Além disso, correlacionar valores de dados antropométricos (massa, altura, % de gordura) com as alterações existentes das [LAC] e [GLI]. Treze voluntários saudáveis realizaram teste incremental em esteira rolante (início a 8km/h, com incrementos de 1km/h a cada 3min até a exaustão). Antes e 3min após a realização do teste incremental foram registrados os valores de [LAC] e [GLI]. Durante cada intensidade do teste incremental foram realizadas avaliações da AP e FP por meio de filmagens no plano sagital. Como resultados, verificou-se que a [LAC] e [GLI] antes do teste incremental (1,94 ± 0,4mmol/L e 94,3 ± 7mg/dL, respectivamente) foram significantemente menores que os valores encontrados após o teste incremental (9,51 ± 2,7mmol/L e 126 ± 16mg/dL, respectivamente). Além disso, verificou-se aumento significante e gradativo da AP e FP ao longo do teste incremental. Correlações inversas e significantes (p Incremental treadmill tests are widely used for prescription of aerobic and anaerobic training. Physiological and kinematics parameters are changed by the progressive nature of this activity. However, there is no consensus on how anthropometric characteristics may affect the incremental test performance. Therefore, the aims of this study were (1) to verify the effects of the incremental treadmill test on the blood lactate concentration ([LAC]), glucose concentration ([GLU]), step frequency (SF) and step length (SL), and (2) to correlate anthropometric data (body mass, height, %body fat) to changes in [LAC] and [GLU]. Thirteen healthy males volunteered to this study and performed an incremental running test on a treadmill (start: 8 km/h, with progressive increases [1 km/h] at each three minute until exhaustion). [LAC] and [GLU] were registered before and 3 min after the incremental test performance. SF and SL were registered for each running speed by digital images at the sagital plane. As results, we verified that [LAC] and [GLU] before the incremental test (1.94 ± 0.4 mmol/L and 94.3 ± 7 mg/dL, respectively) were significantly lower (p < 0.05) than after the incremental test (9.51 ± 2.7 mmol/L and 126 ± 16. mg/dL, respectively). In addition, SF and SL presented significant increase (p < 0.05) throughout the incremental test. [LAC] presented inverse and significant correlations (p < 0.05) to height and body mass. Thus, an incremental treadmill running test affects kinematic (SF and SL) and physiological conditions (muscular fatigue, as consequence of the speed increase). Besides this, shorter and lighter subjects may present higher metabolite concentrations after this type of test

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Thermomechanical characterization of belleville actuators of alloys with shape memory.

No atual estágio do desenvolvimento científico e tecnológico na área de materiais inteligentes, pesquisas em todo o mundo têm originado avanços capazes de permitir sua efetiva utilização como sensores e atuadores, principalmente no caso das Ligas com Memória de Forma (LMF). Esse interesse decorre do fato dessas LMF constituírem materiais metálicos especiais capazes de recuperar deformações residuais de grande intensidade (em média da ordem de 5 % em tração uniaxial), por intermédio de um simples aquecimento. Nesse contexto, este trabalho tem por objetivo geral fabricar e avaliar o comportamento termomecânico bifuncional de atuadores Belleville de L M F (AMFCON) do sistema Ni-Ti, fabricados com tecnologia nacional própria, para geração de força em uniões aparafusadas através do Efeito Memória de Forma e Superelasticidade. Para isso, foram selecionadas L M F de composições 55,3Ni-44,7Ti (% em peso) e 48Ni-38Ti-14Nb (% em peso) que possuem propriedades Superelásticas a temperatura ambiente (~ 27 °C). O método utilizado para realizar a medição da geração de força destes AMFCON em função do tempo e da temperatura, envolveu deformação a temperaturas criogênicas, inferiores a - 50 °C, e aquecimento natural pelo próprio calor ambiente. Os resultados obtidos demonstraram que é possível utilizar-se da bifuncionalidade destes atuadores para aplicações estáticas (uniões aparafusadas) e/ou dinâmicas (elementos de absorção de energia), tendo em vista a medição de forças geradas da ordem de 2,5 kN e Superelasticidade de 40 % com relação a altura do atuador.In current stage of scientific and technological development in the area of smart materiais, researches around the world have originated advances which are able to allow their effective use as sensors and actuators, especially in case of Shape Memory Alloys (SMA). This interest comes from the fact of these SMA being metallic materiais able to recover high amount of residual strain (at about 5% in uniaxial tensile) just by simple heating. In this regard, this study had as main aim to manufacture and evaluate the bifunctional thermomechanical behavior of SMA Belleville actuators (SMACON) from the Ni-Ti alloy system. These elements manufactured with local technology are appropriated for generation of forces in bolted connections through Shape Memory Effect and Superelasticity. For this purpose, there were selected SMA compositions of 55.3Ni-44,7Ti (wt%) and 14Nb-48Ni-38Ti (wt%) which have superelastic properties at room temperature (~ 27 ° C). The method used to carry out the measurement of generated force of SMACON versus time and temperature, involved deformation at cryogenic temperatures, below - 50 ° C, and natural heating by the heat exchange with local environment. The obtained results showed it is possible to use the bifunctionality of the SMACON for static applications (bolted joint) and dynamic (energy dissipation elements), keeping in mind that the generated forces were in the order of 2.5 kN and superelasticity of 40% in relation to height of the actuator

Analysis of Compositional Modification of Commercial Aluminum Bronzes to Obtain Functional Shape Memory Properties

<div><p>In copper-based shape memory alloys (SMAs), some exceptional phenomena, such as the shape memory effect (SME) or superelasticity (SE), are observable. However, commercial aluminum bronzes, Cu3Al-based alloys, do not present these functional properties (SME and/or SE) in their original state. Thus, since one of the main copper-based SMA systems is the Cu-Al-Ni alloy, this paper aims to analyze the modification of these commercial aluminum bronzes to SMA by the addition small amounts of Cu, Al and/or Ni. These modified bronzes were reprocessed by induction melting and injected by centrifugation into a ceramic coating mold. The modifications were made to determine the nominal composition for a Cu-13,0Al-4,0Ni (%wt) SMA. The effectiveness of the modifications was verified by differential scanning calorimetry (DSC) thermal analysis. All modified Cu-Al-Ni bronzes presented DSC peaks of the thermoelastic martensitic phase transformation, showing that SMA behavior was achieved, while the non-modified bronzes revealed no transformation. These results were supported by Vickers hardness (HV), X-ray diffraction (XRD), semi quantitative composition by EDS analysis and optical microscopy.</p></div